96 results
8-K
EX-10.1
NVIVQ
InVivo Therapeutics Holdings Corp
11 Oct 22
InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement
4:23pm
an amendment to certain existing warrants held by the Purchasers (the “Warrant Amendment”).
“Proceeding” means an action, claim, suit, investigation … or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened
8-K
EX-10.2
NVIVQ
InVivo Therapeutics Holdings Corp
11 Oct 22
InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement
4:23pm
, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced … in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company
8-K
EX-4.1
NVIVQ
InVivo Therapeutics Holdings Corp
11 Oct 22
InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement
4:23pm
and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
f) Restrictions. The Holder acknowledges
8-K
EX-10.3
NVIVQ
InVivo Therapeutics Holdings Corp
11 Oct 22
InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement
4:23pm
opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act. The Company shall not file … shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer
8-K
EX-10.1
15zwyde1nauzh8bdlz7k
1 Jun 21
Entry into a Material Definitive Agreement
4:34pm